跳至主要内容
临床试验/NCT03452280
NCT03452280Unknown不适用

Validation of the JADE wRAP™, a Novel Blood Pressure Measurement Device, Using the Same Arm Sequential Method

Jade Healthcare Group Inc.1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2017年12月18日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
140
试验地点
1
主要终点
Validation Criteria 1

研究概览

简要总结

The JADE wRAP™, a wrist worn cuff to measure blood pressure and its supporting software platform is currently at the final alpha prototype stage of development and is not intended for sale.

There are minimal risks with using the JADE wRAP™ device; however, the likelihood of these risks has been reduced through design limitations on electrical power delivered to the device and of the pressure delivered to the cuff portion. Patients should experience little to no discomfort from the inflation of the JADE wRAP™ cuff.

详细描述

The purpose of this study is to validate the JADE wRAP™ in adult patients (≥18 years of age) according to American National Standard, ANSI/AAMI/ISO 81060-2:2013, Non-invasive sphygmomanometers - Part 2: Clinical investigation of automated measurement type.

The study is intended to be a simple validation of blood pressure parameters only (Systolic and Diastolic). This study is not intended to yield any other special information.

OBJECTIVES

  1. To validate the JADE wRAP™ for systolic and diastolic blood pressures compared to the reference standard mercury sphygmomanometer.

The data collected from this study is for internal purposes only and should assist in further developing the device and supporting platform to a beta stage.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must be at least 18 years of age
  • Male or Female
  • Must provide written informed consent prior to the performance of any study-related procedures.

排除标准

  • Subjects who in the opinion of the study staff are too agitated, distressed or who are otherwise unable to cooperate with study procedures
  • Subjects with bigeminy, trigeminy, isolated ventricular premature beat (VPD) or atrial fibrillation or any other condition, in the opinion of the study staff that can result in a significantly irregular heath rhythm.
  • Subjects with signs or recent history of inflammation or infection of the wrists or at the reference clinical test site.

结局指标

主要结局

Validation Criteria 1

时间窗: April 30, 2018

For systolic and diastolic blood pressures, the mean value of the differences of the determinations, of the n individual paired determinations of the JADE wRAPTM and of the observers' determinations with the reference sphygmomanometer for all subjects shall be within or equal to ± 5.0 mmHg (± 0.67 kPa), with a standard deviation, sn, no greater than 8.0 mmHg (1.07 kPa)

次要结局

  • Validation Criteria 2(April 30, 2018)

研究者

发起方
Jade Healthcare Group Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验